On March 25, 2021, the Guangdong Province 2020 Quality Credit Class A Medical Device Manufacturing Enterprise Conference with the theme of "Integrity of Guangdong Devices, Healthy Bay Area Life" was successfully held in Zhongshan. Under the guidance of the Guangdong Provincial Drug Administration, this conference was hosted by the Guangdong Medical Device Management Association. Yan Zhen, Deputy Director of the Guangdong Provincial Drug Administration, Liu Bin, Director of the Greater Bay Area Center for Medical Device Technical Evaluation and Inspection of the National Drug Administration, Medical Device Supervision and Administration Office, Administrative Licensing Office, Law Enforcement Supervision Office, Guangdong Provincial Drug Administration, Guangdong Provincial Medical Device Quality Supervision and Inspection Institute, Guangdong Provincial Drug Administration Evaluation and Certification Center, Guangdong Provincial Drug Administration Drug Adverse Reaction Monitoring Center, Guangdong Provincial Market Supervision Administration Regional Market Inspection Office, Guangdong Provincial Market Supervision Representatives of the Administration attended this meeting. As the rated unit of Guangdong Province's 2020 quality credit A medical device manufacturer, he was invited to attend.

The annual quality credit Class A medical device manufacturers in Guangdong Province are assessed according to the assessment rules in the "Guangdong Province Medical Device Manufacturers' Quality Credit Classification Supervision Work Opinions". The quality credit categories of medical device manufacturers are divided into three categories: A, B, and C based on the relevant provisions of the behavior clause and daily supervision and inspection records.

On March 25, 2021, the Guangdong Province 2020 Quality Credit Class A Medical Device Manufacturing Enterprise Conference with the theme of "Integrity of Guangdong Devices, Healthy Bay Area Life" was successfully held in Zhongshan. Under the guidance of the Guangdong Provincial Drug Administration, this conference was hosted by the Guangdong Medical Device Management Association. Yan Zhen, Deputy Director of the Guangdong Provincial Drug Administration, Liu Bin, Director of the Greater Bay Area Center for Medical Device Technical Evaluation and Inspection of the National Drug Administration, Medical Device Supervision and Administration Office, Administrative Licensing Office, Law Enforcement Supervision Office, Guangdong Provincial Drug Administration, Guangdong Provincial Medical Device Quality Supervision and Inspection Institute, Guangdong Provincial Drug Administration Evaluation and Certification Center, Guangdong Provincial Drug Administration Drug Adverse Reaction Monitoring Center, Guangdong Provincial Market Supervision Administration Regional Market Inspection Office, Guangdong Provincial Market Supervision Representatives of the Administration attended this meeting. As the rated unit of Guangdong Province's 2020 quality credit A medical device manufacturer, he was invited to attend.

The annual quality credit Class A medical device manufacturers in Guangdong Province are assessed according to the assessment rules in the "Guangdong Province Medical Device Manufacturers' Quality Credit Classification Supervision Work Opinions". The quality credit categories of medical device manufacturers are divided into three categories: A, B, and C based on the relevant provisions of the behavior clause and daily supervision and inspection records.